secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lipocine Inc. (LPCN)
CIK:        0001535955
Form:       8-K
Filed at:   2026-09-16T20:38:00+00:00
Accession:  0001493152-26-042933
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lipocine presents at H.C. Wainwright conference; no material news in filing
---------------------------------------------------------------------------

- Presented at H.C. Wainwright 28th Annual Global Investor Conference on Sept 16, 2026 in New York City.
- Filing contains no financial results, guidance, or corporate developments; presentation content not available.
- No specific facts beyond the conference appearance and date are disclosed in the 8-K.
- Ticker LPCN; common stock listed on NASDAQ.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1535955/000149315226042933/0001493152-26-042933-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1535955/000149315226042933/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-042933

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer